ENTITY

Amicus Therapeutics (FOLD US)

6
Analysis
Health Care • United States
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
more
•20 Aug 2025 04:20

Staying Bullish Despite Near-Term Pullback Potential; Buy Pullbacks

Buying a pullback; SPX testing 6400-6410 now, but QQQ and IWM are violating short-term supports at $572 and $226. This makes us believe we could...

Logo
337 Views
Share
•26 Feb 2022 08:00•Issuer-paid

SPAC Talk: Why Underwriters Really Matter in SPAC Land

KEY HIGHLIGHTS Drip, drip, drip: Only two new SPAC IPOs were completed in the past week—media & entertainment SPAC PowerUP Acquisition Corp...

Logo
1.1k Views
Share
•22 Dec 2021 23:00

Continued Absence Of Breakdowns Is A Positive Sign; Many Bottoms-Up Stock Recommendations

As long as the Russell 2000 index (IWM) is above $208, the Russell Micro Caps index (IWC) is above $134-$135, and the S&P 500 is above 4495, we...

Logo
458 Views
Share
bearish•S&P 500 INDEX
•22 Apr 2020 08:38

U.S. Equity Strategy: Several Indicators Suggest a Pullback Likely

Despite the bulls still being in control, we have several ongoing concerns and we cannot rule out the potential for a pullback. Below we highlight...

Logo
544 Views
Share
bearish•Wuxi Biologics
•14 Jan 2019 04:16

WuXi Biologics – The Foxconn or Qualcomm of Global CDMO?

During the first week of 2019, we visited Wuxi Biologics (Cayman) Inc (2269 HK) headquarters in Shanghai, as well as spend time touring the lab....

Logo
951 Views
Share
x